KIAT EUREKA Network Advanced Bio International Joint R&D Project
Funds Korean and European biotechnology teams through international joint innovation collaboration.
The 2026 EUREKA Network Advanced Bio International Joint R&D Project is the first KIAT-administered funding call specifically supporting international collaborative R&D in Korea's advanced bio sector through the EUREKA pan-European network. KIAT announced the call on 27 April 2026 under the Ministry of Trade, Industry and Energy's authority, and active recruitment of participating Korean medical a…
International joint R&D grants pairing Korean medical and biotech companies with European EUREKA-country partners to develop advanced bio technologies through Korea's inaugural EUREKA bio-sector track.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
BudgetGrant Financials and Co-Funding Evidence: Examples for Startup Applications
See examples of grant financials, match funding evidence, co-funding tables, accountant letters, investor commitments, and budget-to-work-plan checks.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
More from KIAT
All grants from this funder →KIAT EUREKA Network Strategic Call — Lightweight Materials
🇰🇷KIAT · South Korea
Funds Korean-led teams and international partners on lightweight materials for transport and manufacturing.
KIAT Regional Industry Strategic R&D Program
🇰🇷KIAT · South Korea
Funds Korean regional teams with coordinated support for collaborative innovation in economic zones and parks.
KIAT World Class Plus Program
🇰🇷KIAT · South Korea
Funds South Korea teams building global category growth for deep-tech from proof to commercialization.
KIAT Bio Industry Open Ecosystem Promotion — Round 2 Integrated
🇰🇷KIAT · South Korea
Funds Korean bio industrial ecosystems by supporting ecosystem development and collaboration.
KIAT EEN Korea Consortium Member Recruitment
🇰🇷KIAT · South Korea
Funds Korean industry organizations that support EEN membership and cross-border business networks.
KIAT Korea-France Industrial Technology International Cooperation Call
🇰🇷KIAT · South Korea
Funds Korean-French teams developing industrial technologies through bilateral cooperation and joint projects.
Similar grants
Browse the directory →
Eureka Network Projects — Permanent
🇪🇺EUREKA · Global / Multinational
Offers open access collaboration through Eureka Network Projects so small enterprises can join international innovation groups.
NRF G-HUB — International R&D Center
🇰🇷NRF · South Korea
Offers frameworks for Korean and international institutions to establish strategic global research center partnerships.
Biotech Call for Network Projects
🇦🇹EUREKA · Global / Multinational
Funds international biotech R&D consortia through each country's own national funding scheme.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
IHI European HealthCare Incubator Network
🇨🇦IHI JU · European Union
Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.
KHIDI Health Industry R&D Promotion (seed)
🇰🇷KHIDI · South Korea
Funds South Korea innovation teams building health-device and drug pipelines from proof to commercialization.